NZ181865A - Oral anabolic compositions containing certain 19-nortestosterone 17 -esters in contunction with a non-steriodal lipid - Google Patents

Oral anabolic compositions containing certain 19-nortestosterone 17 -esters in contunction with a non-steriodal lipid

Info

Publication number
NZ181865A
NZ181865A NZ181865A NZ18186576A NZ181865A NZ 181865 A NZ181865 A NZ 181865A NZ 181865 A NZ181865 A NZ 181865A NZ 18186576 A NZ18186576 A NZ 18186576A NZ 181865 A NZ181865 A NZ 181865A
Authority
NZ
New Zealand
Prior art keywords
contunction
steriodal
nortestosterone
lipid
esters
Prior art date
Application number
NZ181865A
Other languages
English (en)
Inventor
Der Vies J Van
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NZ181865A publication Critical patent/NZ181865A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NZ181865A 1975-08-27 1976-08-26 Oral anabolic compositions containing certain 19-nortestosterone 17 -esters in contunction with a non-steriodal lipid NZ181865A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7510104A NL7510104A (nl) 1975-08-27 1975-08-27 Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.

Publications (1)

Publication Number Publication Date
NZ181865A true NZ181865A (en) 1978-12-18

Family

ID=19824362

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ181865A NZ181865A (en) 1975-08-27 1976-08-26 Oral anabolic compositions containing certain 19-nortestosterone 17 -esters in contunction with a non-steriodal lipid

Country Status (17)

Country Link
US (1) US4083973A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5231063A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU508727B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE845613A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1092025A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2638507A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2321892A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1563302A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR70296B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU176743B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE44533B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL50274A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU75648A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7510104A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ181865A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH12363A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA764868B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
FR2427100A1 (fr) * 1978-06-02 1979-12-28 Kali Chemie Pharma Gmbh Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
US5140021A (en) * 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome
US5208032A (en) * 1988-07-15 1993-05-04 Rutgers, The State University Of New Jersey Increasing the growth of turkeys using implant of 19-nortestosterone
WO1995025504A1 (en) * 1994-03-18 1995-09-28 Pharmavene, Inc. Emulsified drug delivery systems
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US6011027A (en) * 1999-02-18 2000-01-04 Lpj Research, Inc. Use of 19-nor-4-androstenediol to increase 19-nortestosterone levels in humans
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
AU2003231126A1 (en) 2002-04-25 2003-11-10 Banner Pharmacaps, Inc. Chewable soft capsule
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
ES2258694T3 (es) * 2003-11-11 2006-09-01 Mattern, Udo Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales.
CN1257711C (zh) * 2003-12-05 2006-05-31 石药集团中奇制药技术(石家庄)有限公司 丁苯酞软胶囊及其制备工艺
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
FI3456329T3 (fi) 2005-10-12 2025-02-27 Besins Healthcare Lu Sarl Parannettu testosteronigeeli ja käyttömenetelmä
RU2480208C2 (ru) 2006-10-04 2013-04-27 М Унд П Патент Акциенгезелльшафт Система доставки с контролируемым высвобождением для назального применения нейротрансмиттеров
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
RU2708238C2 (ru) 2014-06-17 2019-12-05 Мерк Шарп и Доум Б.В. Стабильные составы тестостерона ундеканоата

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998423A (en) * 1958-02-25 1961-08-29 Organon Esters of 19-nortestosterone
US3016388A (en) * 1959-06-30 1962-01-09 Organon New esters of 19-nor-testosterone
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
IL50274A0 (en) 1976-10-31
GR70296B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-09-06
IE44533L (en) 1977-02-27
HU176743B (en) 1981-05-28
AU508727B2 (en) 1980-04-03
AU1698076A (en) 1978-02-23
FR2321892B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-05-25
IE44533B1 (en) 1981-12-30
IL50274A (en) 1980-11-30
LU75648A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-03-31
DE2638507A1 (de) 1977-03-03
NL7510104A (nl) 1977-03-01
PH12363A (en) 1979-01-29
GB1563302A (en) 1980-03-26
BE845613A (fr) 1977-02-28
ZA764868B (en) 1977-07-27
FR2321892A1 (fr) 1977-03-25
JPS5231063A (en) 1977-03-09
US4083973A (en) 1978-04-11
CA1092025A (en) 1980-12-23

Similar Documents

Publication Publication Date Title
NZ181865A (en) Oral anabolic compositions containing certain 19-nortestosterone 17 -esters in contunction with a non-steriodal lipid
GB1553731A (en) Oestrogenic compositions for oral administration
GB1544635A (en) Combustible composition
ZA766466B (en) A system for gasifying fuels in finegrain form
HK6380A (en) Improvements relating to self-clinching fasteners
JPS5237176A (en) Ampule
ZA753459B (en) Oral dosing
NZ182247A (en) Lipid containing feed supplements
AU513930B2 (en) Fuel supply device
NZ190704A (en) Plasticizer composition-use thereof for puttylike composition
JPS5273230A (en) Fuel feeding device
JPS5386046A (en) Oral antiibacterial composition
JPS5280305A (en) Fuel composition
JPS51144833A (en) Carburetor
JPS5331716A (en) Enamel for dentist
JPS5269401A (en) Fuel
JPS5225757A (en) Vinyl thionophosphate ester
GB1548407A (en) Copolyesters blends
JPS5264195A (en) Dental unit
JPS5244097A (en) Batteryycontaining dental motorrdriven cutter charger
JPS51119525A (en) Fuel feeder
JPS5257435A (en) Carburetor
JPS528225A (en) Fuel feeding device
JPS5251030A (en) Dental pharmacy for increasing mouth sanitation
HK22480A (en) Feeding bottles